Avidity Biosciences, Inc. (RNAM)
72.82
+1.47
(+2.07%)
USD |
NASDAQ |
Feb 27, 16:00
Avidity Biosciences Total Liabilities (Quarterly) : 269.45M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Novartis AG | 69.02B |
| Dyne Therapeutics, Inc. | 175.28M |
| BioMarin Pharmaceutical, Inc. | 1.507B |
| Insmed, Inc. | 1.526B |
| Revolution Medicines, Inc. | 777.09M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.958B |
| Shareholders Equity (Quarterly) | 1.689B |
| Debt to Equity Ratio | 0.0292 |
| Current Ratio | 9.202 |
| Net Debt Paydown Yield | -0.08% |